Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.

Conditions:   Head Neck Cancer;   Radiation Neuropathy;   Pain, Neuropathic Interventions:   Drug: Gabapentin;   Other: Placebo Sponsors:   University Hospital, Ghent;   General Hospital Groeninge;   Catholic University Leuven (Kulak), Kortrijk, Belgium;   Anglia Ruskin University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials